118491,1,Admission,O
118491,1,Date,O
118491,1,:,O
118491,1,[,O
118491,1,**2106-5-27**,O
118491,1,],O
118491,1,Discharge,O
118491,1,Date,O
118491,1,:,O
118491,1,[,O
118491,1,**2106-6-20**,O
118491,1,],O
118491,1,Date,O
118491,1,of,O
118491,1,Birth,O
118491,1,:,O
118491,1,[,O
118491,1,**2060-12-28**,O
118491,1,],O
118491,1,Sex,O
118491,1,:,O
118491,1,F,O
118491,1,Service,O
118491,1,:,O
118491,1,MEDICINE,O
118491,1,Allergies,O
118491,1,:,O
118491,1,Benzodiazepines,B-Drug
118491,1,/,O
118491,1,Furosemide,B-Drug
118491,1,Attending,O
118491,1,:,O
118491,1,[,O
118491,1,**First,O
118491,1,Name3,O
118491,1,(,O
118491,1,LF,O
118491,1,),O
118491,1,330**,O
118491,1,],O
118491,1,Chief,O
118491,1,Complaint,O
118491,1,:,O
118491,1,Evaluation,O
118491,1,for,O
118491,1,liver,O
118491,1,transplant,O
118491,1,Major,O
118491,1,Surgical,O
118491,1,or,O
118491,1,Invasive,O
118491,1,Procedure,O
118491,1,:,O
118491,1,1,O
118491,1,.,O
118491,1,EGD,O
118491,1,2,O
118491,1,.,O
118491,1,Post-pyloric,O
118491,1,feeding,O
118491,1,tube,O
118491,1,x,O
118491,1,3,O
118491,1,3,O
118491,1,.,O
118491,1,Paracentesis,O
118491,1,4,O
118491,1,.,O
118491,1,PICC,O
118491,1,line,O
118491,1,placement,O
118491,1,x,O
118491,1,2,O
118491,1,History,O
118491,1,of,O
118491,1,Present,O
118491,1,Illness,O
118491,1,:,O
118491,1,45F,O
118491,1,with,O
118491,1,ESLD,O
118491,1,secondary,O
118491,1,to,O
118491,1,EtOH,O
118491,1,",",O
118491,1,AIHA,B-ADE
118491,1,due,O
118491,1,to,O
118491,1,lasix,B-Drug
118491,1,recently,O
118491,1,on,O
118491,1,prednisone,B-Drug
118491,1,who,O
118491,1,was,O
118491,1,initially,O
118491,1,presented,O
118491,1,to,O
118491,1,OSH,O
118491,1,with,O
118491,1,hepatic,O
118491,1,encephalopathy,O
118491,1,transferred,O
118491,1,from,O
118491,1,OSH,O
118491,1,on,O
118491,1,[,O
118491,1,**5-27**,O
118491,1,],O
118491,1,for,O
118491,1,liver,O
118491,1,transplant,O
118491,1,evaluation,O
118491,1,whose,O
118491,1,course,O
118491,1,has,O
118491,1,been,O
118491,1,complicated,O
118491,1,by,O
118491,1,coagulopathy,O
118491,1,with,O
118491,1,recurrent,O
118491,1,epistaxis,O
118491,1,",",O
118491,1,VRE,O
118491,1,bacteremia,O
118491,1,",",O
118491,1,new,O
118491,1,onset,O
118491,1,Afib,O
118491,1,with,O
118491,1,RVR,O
118491,1,and,O
118491,1,now,O
118491,1,with,O
118491,1,worsening,O
118491,1,leukocytosis,O
118491,1,and,O
118491,1,diffuse,O
118491,1,bilat,O
118491,1,pulmonary,O
118491,1,infiltrates,O
118491,1,.,O
118491,1,.,O
118491,1,To,O
118491,1,summarize,O
118491,1,her,O
118491,1,recent,O
118491,1,course,O
118491,1,",",O
118491,1,the,O
118491,1,patient,O
118491,1,was,O
118491,1,admitted,O
118491,1,to,O
118491,1,OSH,O
118491,1,from,O
118491,1,[,O
118491,1,**Date,O
118491,1,range,O
118491,1,(,O
118491,1,1,O
118491,1,),O
118491,1,74368**,O
118491,1,],O
118491,1,for,O
118491,1,hemolytic,B-ADE
118491,1,anemia,I-ADE
118491,1,thought,O
118491,1,to,O
118491,1,be,O
118491,1,[,O
118491,1,**1-15**,O
118491,1,],O
118491,1,lasix,B-Drug
118491,1,and,O
118491,1,was,O
118491,1,started,O
118491,1,on,O
118491,1,prednisone,B-Drug
118491,1,50mg,O
118491,1,.,O
118491,1,On,O
118491,1,[,O
118491,1,**5-22**,O
118491,1,],O
118491,1,",",O
118491,1,she,O
118491,1,represented,O
118491,1,with,O
118491,1,hepatic,O
118491,1,encephalopathy,O
118491,1,and,O
118491,1,T,O
118491,1,[,O
118491,1,**Age,O
118491,1,over,O
118491,1,90,O
118491,1,**,O
118491,1,],O
118491,1,F,O
118491,1,where,O
118491,1,she,O
118491,1,underwent,O
118491,1,paracentesis,O
118491,1,with,O
118491,1,negative,O
118491,1,cultures,O
118491,1,.,O
118491,1,CXR,O
118491,1,showed,O
118491,1,b/l,O
118491,1,infiltrates,O
118491,1,and,O
118491,1,she,O
118491,1,received,O
118491,1,tx,O
118491,1,with,O
118491,1,vanco,B-Drug
118491,1,",",O
118491,1,levoflox,B-Drug
118491,1,",",O
118491,1,and,O
118491,1,zosyn,B-Drug
118491,1,and,O
118491,1,she,O
118491,1,was,O
118491,1,transferred,O
118491,1,to,O
118491,1,[,O
118491,1,**Hospital1,O
118491,1,18**,O
118491,1,],O
118491,1,for,O
118491,1,liver,O
118491,1,transplant,O
118491,1,eval,O
118491,1,.,O
118491,1,.,O
118491,1,At,O
118491,1,[,O
118491,1,**Hospital1,O
118491,1,18**,O
118491,1,],O
118491,1,",",O
118491,1,she,O
118491,1,was,O
118491,1,noted,O
118491,1,to,O
118491,1,have,O
118491,1,numerous,O
118491,1,small,O
118491,1,pulmonary,O
118491,1,nodules,O
118491,1,on,O
118491,1,[,O
118491,1,**5-29**,O
118491,1,],O
118491,1,chest,O
118491,1,CT,O
118491,1,of,O
118491,1,unclear,O
118491,1,significance,O
118491,1,.,O
118491,1,Pulm,O
118491,1,consulted,O
118491,1,for,O
118491,1,?,O
118491,1,bronch,O
118491,1,given,O
118491,1,concern,O
118491,1,for,O
118491,1,infection,O
118491,1,vs.,O
118491,1,malignancy,O
118491,1,.,O
118491,1,Due,O
118491,1,to,O
118491,1,worsening,O
118491,1,confusion,O
118491,1,the,O
118491,1,patient,O
118491,1,underwent,O
118491,1,repeat,O
118491,1,paracentesis,O
118491,1,with,O
118491,1,135,O
118491,1,WBC,O
118491,1,.,O
118491,1,Eventually,O
118491,1,blood,O
118491,1,cultures,O
118491,1,from,O
118491,1,[,O
118491,1,**6-11**,O
118491,1,],O
118491,1,returned,O
118491,1,[,O
118491,1,**12-17**,O
118491,1,],O
118491,1,bottles,O
118491,2,+ve,O
118491,2,for,O
118491,2,VRE,B-Reason
118491,2,and,O
118491,2,was,O
118491,2,started,O
118491,2,on,O
118491,2,daptomycin,B-Drug
118491,2,.,O
118491,2,Likely,O
118491,2,source,O
118491,2,was,O
118491,2,colonization,O
118491,2,of,O
118491,2,urine,O
118491,2,discovered,O
118491,2,on,O
118491,2,[,O
118491,2,**5-30**,O
118491,2,],O
118491,2,.,O
118491,2,Also,O
118491,2,on,O
118491,2,[,O
118491,2,**6-11**,O
118491,2,],O
118491,2,",",O
118491,2,the,O
118491,2,patient,O
118491,2,was,O
118491,2,started,O
118491,2,on,O
118491,2,CTX,B-Drug
118491,2,for,O
118491,2,positive,O
118491,2,U/A,O
118491,2,which,O
118491,2,was,O
118491,2,then,O
118491,2,continued,O
118491,2,per,O
118491,2,ID,O
118491,2,to,O
118491,2,empirically,O
118491,2,cover,O
118491,2,possible,O
118491,2,SBP,B-Reason
118491,2,.,O
118491,2,Also,O
118491,2,treated,O
118491,2,for,O
118491,2,hepatorenal,B-Reason
118491,2,syndrome,I-Reason
118491,2,(,O
118491,2,cre,O
118491,2,1.5,O
118491,2,which,O
118491,2,improved,O
118491,2,to,O
118491,2,0.4,O
118491,2,),O
118491,2,with,O
118491,2,albumin,B-Drug
118491,2,",",O
118491,2,midodrine,B-Drug
118491,2,",",O
118491,2,and,O
118491,2,octreotide,B-Drug
118491,2,x,O
118491,2,4,O
118491,2,days,O
118491,2,",",O
118491,2,which,O
118491,2,was,O
118491,2,d/c,O
118491,2,'d,O
118491,2,on,O
118491,2,[,O
118491,2,**6-16**,O
118491,2,],O
118491,2,given,O
118491,2,improvement,O
118491,2,in,O
118491,2,renal,O
118491,2,function,O
118491,2,.,O
118491,2,.,O
118491,2,On,O
118491,2,[,O
118491,2,**6-14**,O
118491,2,],O
118491,2,",",O
118491,2,the,O
118491,2,patient,O
118491,2,developed,O
118491,2,significant,B-Reason
118491,2,epistaxis,I-Reason
118491,2,requiring,O
118491,2,multiple,O
118491,2,FFP,B-Drug
118491,2,",",O
118491,2,platelet,B-Drug
118491,2,",",O
118491,2,and,O
118491,2,RBC,B-Drug
118491,2,transfusions,O
118491,2,.,O
118491,2,There,O
118491,2,was,O
118491,2,concern,O
118491,2,for,O
118491,2,aspiration,O
118491,2,given,O
118491,2,altered,O
118491,2,mental,O
118491,2,status,O
118491,2,.,O
118491,2,Despite,O
118491,2,continued,O
118491,2,G+,O
118491,2,black,O
118491,2,stools,O
118491,2,her,O
118491,2,Hct,O
118491,2,has,O
118491,2,been,O
118491,2,stable,O
118491,2,since,O
118491,2,[,O
118491,2,**6-15**,O
118491,2,],O
118491,2,.,O
118491,2,On,O
118491,2,[,O
118491,2,**6-16**,O
118491,2,],O
118491,2,",",O
118491,2,the,O
118491,2,medical,O
118491,2,team,O
118491,2,repeated,O
118491,2,her,O
118491,2,CT,O
118491,2,chest,O
118491,2,to,O
118491,2,eval,O
118491,2,for,O
118491,2,progression,O
118491,2,of,O
118491,2,pulmonary,O
118491,2,nodules,O
118491,2,and,O
118491,2,found,O
118491,2,bilateral,O
118491,2,infiltrates,O
118491,2,concerning,O
118491,2,for,O
118491,2,infection,O
118491,2,",",O
118491,2,bleeding,O
118491,2,",",O
118491,2,or,O
118491,2,aspiration,O
118491,2,.,O
118491,2,She,O
118491,2,was,O
118491,2,started,O
118491,2,on,O
118491,2,bactrim,B-Drug
118491,2,for,O
118491,2,possible,O
118491,2,PCP,B-Reason
118491,2,given,O
118491,2,her,O
118491,2,recent,O
118491,2,prolonged,O
118491,2,predinsone,B-Drug
118491,2,course,O
118491,2,that,O
118491,2,had,O
118491,2,been,O
118491,2,discontinued,O
118491,2,on,O
118491,2,[,O
118491,2,**6-15**,O
118491,2,],O
118491,2,.,O
118491,2,Also,O
118491,2,on,O
118491,2,[,O
118491,2,**6-16**,O
118491,2,],O
118491,2,developed,O
118491,2,new-onset,O
118491,2,Afib,B-Reason
118491,2,with,I-Reason
118491,2,RVR,I-Reason
118491,2,150s,O
118491,2,that,O
118491,2,responded,O
118491,2,to,O
118491,2,diltiazem,B-Drug
118491,2,.,O
118491,2,Due,O
118491,2,to,O
118491,2,increased,O
118491,2,volume,O
118491,2,of,O
118491,2,diarrhea,O
118491,2,and,O
118491,2,climbing,O
118491,2,WBC,O
118491,2,count,O
118491,2,she,O
118491,2,was,O
118491,2,started,O
118491,2,on,O
118491,2,empiric,B-Reason
118491,2,flagyl,O
118491,2,on,O
118491,2,[,O
118491,2,**2106-6-17**,O
118491,2,],O
118491,2,.,O
118491,2,.,O
118491,2,On,O
118491,2,transfer,O
118491,2,to,O
118491,2,the,O
118491,2,MICU,O
118491,2,",",O
118491,2,the,O
118491,2,patient,O
118491,2,denies,O
118491,2,any,O
118491,2,complaints,O
118491,2,including,O
118491,2,shortness,O
118491,2,of,O
118491,2,breath,O
118491,2,",",O
118491,2,chest,O
118491,2,pain,O
118491,2,",",O
118491,2,headache,O
118491,2,",",O
118491,2,confusion,O
118491,2,.,O
118491,2,Past,O
118491,2,Medical,O
118491,2,History,O
118491,2,:,O
118491,2,EtOH,O
118491,2,cirrhosis,O
118491,2,s/p,O
118491,2,TIPS,O
118491,2,for,O
118491,2,varices,O
118491,2,in,O
118491,2,[,O
118491,2,**2102**,O
118491,2,],O
118491,2,with,O
118491,2,multiple,O
118491,2,revisions,O
118491,2,gastric,O
118491,2,varices,O
118491,2,hepatic,O
118491,2,encephalopathy,O
118491,2,spur,O
118491,2,cell,O
118491,2,anemia,O
118491,2,chronic,O
118491,2,hyponatremia,O
118491,2,autoimmune,B-ADE
118491,2,hemolytic,I-ADE
118491,2,anemia,I-ADE
118491,2,(,O
118491,2,from,O
118491,2,lasix,B-Drug
118491,2,?,O
118491,2,),O
118491,2,on,O
118491,2,prednisone,B-Drug
118491,2,h/o,O
118491,2,ovarian,O
118491,2,cysts,O
118491,2,Social,O
118491,2,History,O
118491,2,:,O
118491,2,Lives,O
118491,2,with,O
118491,2,husband,O
118491,2,",",O
118491,2,[,O
118491,2,**Name,O
118491,2,(,O
118491,2,NI,O
118491,2,),O
118491,2,**,O
118491,3,],O
118491,3,",",O
118491,3,who,O
118491,3,is,O
118491,3,very,O
118491,3,involved,O
118491,3,in,O
118491,3,her,O
118491,3,care,O
118491,3,.,O
118491,3,No,O
118491,3,children,O
118491,3,.,O
118491,3,No,O
118491,3,tobacco,O
118491,3,use,O
118491,3,ever,O
118491,3,.,O
118491,3,Significant,O
118491,3,EtOH,O
118491,3,history,O
118491,3,",",O
118491,3,sober,O
118491,3,since,O
118491,3,[,O
118491,3,**2105-11-28**,O
118491,3,],O
118491,3,.,O
118491,3,Involved,O
118491,3,in,O
118491,3,AA,O
118491,3,.,O
118491,3,Reported,O
118491,3,PTSD,O
118491,3,s/p,O
118491,3,attack,O
118491,3,by,O
118491,3,father,O
118491,3,as,O
118491,3,a,O
118491,3,child/teenager,O
118491,3,.,O
118491,3,.,O
118491,3,Previously,O
118491,3,worked,O
118491,3,as,O
118491,3,a,O
118491,3,lawyer,O
118491,3,",",O
118491,3,studied,O
118491,3,at,O
118491,3,[,O
118491,3,**Name,O
118491,3,(,O
118491,3,NI,O
118491,3,),O
118491,3,17448**,O
118491,3,],O
118491,3,Law,O
118491,3,School,O
118491,3,.,O
118491,3,Family,O
118491,3,History,O
118491,3,:,O
118491,3,No,O
118491,3,liver,O
118491,3,disease,O
118491,3,.,O
118491,3,Alcoholism,O
118491,3,in,O
118491,3,father,O
118491,3,.,O
118491,3,Physical,O
118491,3,Exam,O
118491,3,:,O
118491,3,Admission,O
118491,3,Physical,O
118491,3,Exam,O
118491,3,Vitals,O
118491,3,:,O
118491,3,T,O
118491,3,:,O
118491,3,99.3,O
118491,3,BP,O
118491,3,:,O
118491,3,100/60,O
118491,3,P,O
118491,3,:,O
118491,3,74,O
118491,3,RR,O
118491,3,:,O
118491,3,20,O
118491,3,SpO2,O
118491,3,:,O
118491,3,96,O
118491,3,%,O
118491,3,RA,O
118491,3,wt,O
118491,3,47,O
118491,3,kg,O
118491,3,General,O
118491,3,:,O
118491,3,Awake,O
118491,3,",",O
118491,3,alert,O
118491,3,",",O
118491,3,lying,O
118491,3,flat,O
118491,3,in,O
118491,3,bed,O
118491,3,in,O
118491,3,NAD,O
118491,3,.,O
118491,3,grossly,O
118491,3,jaundiced,O
118491,3,",",O
118491,3,thin,O
118491,3,.,O
118491,3,HEENT,O
118491,3,:,O
118491,3,EOMI,O
118491,3,",",O
118491,3,sclera,O
118491,3,icteric,O
118491,3,.,O
118491,3,MMM,O
118491,3,",",O
118491,3,OP,O
118491,3,without,O
118491,3,lesions,O
118491,3,Neck,O
118491,3,:,O
118491,3,supple,O
118491,3,",",O
118491,3,no,O
118491,3,JVD,O
118491,3,appreciated,O
118491,3,Pulm,O
118491,3,:,O
118491,3,mild,O
118491,3,crackles,O
118491,3,to,O
118491,3,b/t,O
118491,3,bases,O
118491,3,Cardiac,O
118491,3,:,O
118491,3,RRR,O
118491,3,",",O
118491,3,nl,O
118491,3,S1/S2,O
118491,3,",",O
118491,3,2/6,O
118491,3,systolic,O
118491,3,murmur,O
118491,3,Abdomen,O
118491,3,:,O
118491,3,soft,O
118491,3,",",O
118491,3,tender,O
118491,3,to,O
118491,3,deep,O
118491,3,palpation,O
118491,3,to,O
118491,3,epigastrum,O
118491,3,.,O
118491,3,no,O
118491,3,rebound/guarding,O
118491,3,.,O
118491,3,ND,O
118491,3,",",O
118491,3,+,O
118491,3,BS,O
118491,3,",",O
118491,3,no,O
118491,3,hepatomegaly,O
118491,3,noted,O
118491,3,.,O
118491,3,Rectal,O
118491,3,:,O
118491,3,guaiac,O
118491,3,negative,O
118491,3,at,O
118491,3,OSH,O
118491,3,Ext,O
118491,3,:,O
118491,3,No,O
118491,3,edema,O
118491,3,b/t,O
118491,3,",",O
118491,3,warm,O
118491,3,.,O
118491,3,Skin,O
118491,3,:,O
118491,3,spider,O
118491,3,telangiectasias,O
118491,3,to,O
118491,3,chest,O
118491,3,",",O
118491,3,grossly,O
118491,3,jaundiced,O
118491,3,Neurologic,O
118491,3,:,O
118491,3,-mental,O
118491,3,status,O
118491,3,:,O
118491,3,Alert,O
118491,3,&,O
118491,3,Oriented,O
118491,3,x,O
118491,3,3,O
118491,3,.,O
118491,3,Able,O
118491,3,to,O
118491,3,relate,O
118491,3,history,O
118491,3,",",O
118491,3,but,O
118491,3,with,O
118491,3,some,O
118491,3,memory,O
118491,3,lapses,O
118491,3,.,O
118491,3,-cranial,O
118491,3,nerves,O
118491,3,:,O
118491,3,II-XII,O
118491,3,intact,O
118491,3,-motor,O
118491,3,:,O
118491,3,[,O
118491,3,**3-18**,O
118491,3,],O
118491,3,UE,O
118491,3,strength,O
118491,3,",",O
118491,3,[,O
118491,3,**4-17**,O
118491,3,],O
118491,3,LE,O
118491,3,.,O
118491,3,-sensory,O
118491,3,:,O
118491,3,No,O
118491,3,deficits,O
118491,3,to,O
118491,3,light,O
118491,3,touch,O
118491,3,throughout,O
118491,3,.,O
118491,3,-no,O
118491,3,asterixis,O
118491,3,.,O
118491,3,ICU,O
118491,3,Admission,O
118491,3,Physical,O
118491,3,Exam,O
118491,3,:,O
118491,3,T,O
118491,3,96.1,O
118491,3,HR,O
118491,3,125,O
118491,3,BP,O
118491,3,113/59,O
118491,3,RR,O
118491,3,23,O
118491,3,SaO2,O
118491,3,98,O
118491,3,%,O
118491,3,on,O
118491,3,RA,O
118491,3,General,O
118491,3,:,O
118491,3,Ill-appearing,O
118491,3,",",O
118491,3,jaundiced,O
118491,3,HEENT,O
118491,3,:,O
118491,3,PERRL,O
118491,3,",",O
118491,3,EOMi,O
118491,3,",",O
118491,3,icteric,O
118491,3,sclera,O
118491,3,",",O
118491,3,mouth,O
118491,3,and,O
118491,3,nares,O
118491,3,with,O
118491,3,crusted,O
118491,3,blood,O
118491,3,",",O
118491,3,OP,O
118491,3,clear,O
118491,3,Neck,O
118491,3,:,O
118491,3,supple,O
118491,3,",",O
118491,3,trachea,O
118491,3,midline,O
118491,3,",",O
118491,4,no,O
118491,4,masses,O
118491,4,",",O
118491,4,no,O
118491,4,LAD,O
118491,4,Cardiac,O
118491,4,:,O
118491,4,tachycardic,O
118491,4,",",O
118491,4,[,O
118491,4,**Last,O
118491,4,Name,O
118491,4,(,O
118491,4,un,O
118491,4,),O
118491,4,3526**,O
118491,4,],O
118491,4,[,O
118491,4,**Last,O
118491,4,Name,O
118491,4,(,O
118491,4,un,O
118491,4,),O
118491,4,3526**,O
118491,4,],O
118491,4,",",O
118491,4,s1s2,O
118491,4,normal,O
118491,4,",",O
118491,4,friction,O
118491,4,rub,O
118491,4,noted,O
118491,4,at,O
118491,4,LUSB,O
118491,4,4th,O
118491,4,intercostal,O
118491,4,space,O
118491,4,",",O
118491,4,no,O
118491,4,m/g,O
118491,4,Pulmonary,O
118491,4,:,O
118491,4,bilateral,O
118491,4,crackles,O
118491,4,(,O
118491,4,L,O
118491,4,>,O
118491,4,R,O
118491,4,),O
118491,4,Abdomen,O
118491,4,:,O
118491,4,+BS,O
118491,4,",",O
118491,4,soft,O
118491,4,",",O
118491,4,nontender,O
118491,4,",",O
118491,4,distended,O
118491,4,",",O
118491,4,+ascites,O
118491,4,Extremities,O
118491,4,:,O
118491,4,warm,O
118491,4,",",O
118491,4,2+,O
118491,4,bilateral,O
118491,4,LE,O
118491,4,edema,O
118491,4,Neuro,O
118491,4,:,O
118491,4,A,O
118491,4,&,O
118491,4,Ox3,O
118491,4,",",O
118491,4,speech,O
118491,4,clear,O
118491,4,",",O
118491,4,CNII-XII,O
118491,4,intact,O
118491,4,",",O
118491,4,no,O
118491,4,asterixis,O
118491,4,Pertinent,O
118491,4,Results,O
118491,4,:,O
118491,4,Admission,O
118491,4,Labs,O
118491,4,:,O
118491,4,==============,O
118491,4,[,O
118491,4,**2106-5-27**,O
118491,4,],O
118491,4,CBC/DIFF,O
118491,4,:,O
118491,4,WBC-19.9*,O
118491,4,RBC-2.56*,O
118491,4,HGB-9.3*,O
118491,4,HCT-24.5*,O
118491,4,MCV-96,O
118491,4,MCH-36.3*,O
118491,4,MCHC-37.8,O
118491,4,PLT,O
118491,4,39,O
118491,4,NEUTS-91.4*,O
118491,4,LYMPHS-4.1*,O
118491,4,MONOS-4.3,O
118491,4,EOS-0.1,O
118491,4,BASOS-0.1,O
118491,4,[,O
118491,4,**2106-5-27**,O
118491,4,],O
118491,4,ALBUMIN-2.4*,O
118491,4,CALCIUM-9.5,O
118491,4,PHOSPHATE-2.5*,O
118491,4,MAGNESIUM-2.2,O
118491,4,IRON-183*,O
118491,4,CHOLEST-92,O
118491,4,[,O
118491,4,**2106-5-27**,O
118491,4,],O
118491,4,LFTs,O
118491,4,:,O
118491,4,ALT,O
118491,4,(,O
118491,4,SGPT,O
118491,4,),O
118491,4,-51*,O
118491,4,AST,O
118491,4,(,O
118491,4,SGOT,O
118491,4,),O
118491,4,-89*,O
118491,4,LD,O
118491,4,(,O
118491,4,LDH,O
118491,4,),O
118491,4,-990*,O
118491,4,ALK,O
118491,4,PHOS-114,O
118491,4,TOT,O
118491,4,BILI-32.0*,O
118491,4,DIR,O
118491,4,BILI-15.2*,O
118491,4,INDIR,O
118491,4,BIL-16.8,O
118491,4,[,O
118491,4,**2106-5-27**,O
118491,4,],O
118491,4,CHEM,O
118491,4,7,O
118491,4,GLUCOSE-101,O
118491,4,UREA,O
118491,4,N-38*,O
118491,4,CREAT-0.6,O
118491,4,SODIUM-121*,O
118491,4,POTASSIUM-4.0,O
118491,4,CHLORIDE-87*,O
118491,4,TOTAL,O
118491,4,CO2-29,O
118491,4,ANION,O
118491,4,GAP-9,O
118491,4,[,O
118491,4,**2106-5-27**,O
118491,4,],O
118491,4,11:40PM,O
118491,4,PT-23.0*,O
118491,4,PTT-49.0*,O
118491,4,INR,O
118491,4,(,O
118491,4,PT,O
118491,4,),O
118491,4,-2.3*,O
118491,4,.,O
118491,4,Serologies,O
118491,4,:,O
118491,4,==========,O
118491,4,[,O
118491,4,**2106-5-27**,O
118491,4,],O
118491,4,HCV,O
118491,4,Ab-NEGATIVE,O
118491,4,[,O
118491,4,**2106-5-27**,O
118491,4,],O
118491,4,HBsAg-NEGATIVE,O
118491,4,HBs,O
118491,4,Ab-POSITIVE,O
118491,4,HBc,O
118491,4,Ab-NEGATIVE,O
118491,4,HAV,O
118491,4,Ab-POSITIVE,O
118491,4,.,O
118491,4,MICRO,O
118491,4,:,O
118491,4,======,O
118491,4,-Blood,O
118491,4,Cultures,O
118491,4,6/15,O
118491,4,",",O
118491,4,[,O
118491,4,**5-30**,O
118491,4,],O
118491,4,:,O
118491,4,Negative,O
118491,4,-RPR,O
118491,4,non-reactive,O
118491,4,-Rubella,O
118491,4,Immune,O
118491,4,-Varicella,O
118491,4,IgG,O
118491,4,positive,O
118491,4,.,O
118491,4,Lipids,O
118491,4,:,O
118491,4,======,O
118491,4,[,O
118491,4,**2106-5-27**,O
118491,4,],O
118491,4,LIPIDS,O
118491,4,:,O
118491,4,TRIGLYCER-87,O
118491,4,HDL,O
118491,4,CHOL-45,O
118491,4,CHOL/HDL-2.0,O
118491,4,LDL,O
118491,4,(,O
118491,4,CALC,O
118491,4,),O
118491,4,-30,O
118491,4,.,O
118491,4,IRON,O
118491,4,STUDIES,O
118491,4,:,O
118491,4,TIBC-181*,O
118491,4,HAPTOGLOB-,O
118491,4,<,O
118491,4,20*,O
118491,4,FERRITIN-1524*,O
118491,4,TRF-139*,O
118491,4,.,O
118491,4,RADIOLOGY,O
118491,4,:,O
118491,4,=========,O
118491,4,[,O
118491,4,**5-28**,O
118491,4,],O
118491,4,ABD,O
118491,4,U/S-,O
118491,4,DOPPLER,O
118491,4,LIVER,O
118491,4,ULTRASOUND,O
118491,4,:,O
118491,4,No,O
118491,4,prior,O
118491,4,studies,O
118491,4,are,O
118491,4,available,O
118491,4,for,O
118491,4,comparison,O
118491,4,.,O
118491,4,The,O
118491,4,TIPS,O
118491,4,is,O
118491,4,patent,O
118491,4,with,O
118491,4,wall-to-wall,O
118491,4,color,O
118491,4,flow,O
118491,4,.,O
118491,4,There,O
118491,4,is,O
118491,4,appropriate,O
118491,4,flow,O
118491,4,reversal,O
118491,4,(,O
118491,4,hepatofugal,O
118491,4,),O
118491,4,within,O
118491,4,the,O
118491,4,left,O
118491,4,portal,O
118491,4,vein,O
118491,4,.,O
118491,4,The,O
118491,4,assessment,O
118491,4,of,O
118491,4,the,O
118491,4,right,O
118491,4,anterior,O
118491,4,and,O
118491,4,posterior,O
118491,4,portal,O
118491,4,veins,O
118491,4,was,O
118491,4,limited,O
118491,4,as,O
118491,4,the,O
118491,4,liver,O
118491,4,is,O
118491,4,extremely,O
118491,5,shrunken,O
118491,5,and,O
118491,5,nodular,O
118491,5,.,O
118491,5,The,O
118491,5,following,O
118491,5,velocities,O
118491,5,were,O
118491,5,obtained,O
118491,5,:,O
118491,5,Main,O
118491,5,portal,O
118491,5,vein,O
118491,5,35,O
118491,5,cm/sec,O
118491,5,;,O
118491,5,proximal,O
118491,5,TIPS,O
118491,5,67,O
118491,5,cm/sec,O
118491,5,;,O
118491,5,mid,O
118491,5,TIPS,O
118491,5,73,O
118491,5,cm/sec,O
118491,5,;,O
118491,5,distal,O
118491,5,tips,O
118491,5,74,O
118491,5,cm/sec,O
118491,5,.,O
118491,5,The,O
118491,5,receiving,O
118491,5,hepatic,O
118491,5,vein,O
118491,5,is,O
118491,5,patent,O
118491,5,.,O
118491,5,.,O
118491,5,There,O
118491,5,is,O
118491,5,a,O
118491,5,small,O
118491,5,amount,O
118491,5,of,O
118491,5,ascites,O
118491,5,surrounding,O
118491,5,the,O
118491,5,liver,O
118491,5,",",O
118491,5,relatively,O
118491,5,less,O
118491,5,in,O
118491,5,the,O
118491,5,lower,O
118491,5,quadrants,O
118491,5,.,O
118491,5,The,O
118491,5,liver,O
118491,5,is,O
118491,5,extremely,O
118491,5,shrunken,O
118491,5,and,O
118491,5,nodular,O
118491,5,with,O
118491,5,very,O
118491,5,heterogeneous,O
118491,5,echotexture,O
118491,5,.,O
118491,5,Anterior,O
118491,5,to,O
118491,5,the,O
118491,5,TIPS,O
118491,5,stent,O
118491,5,are,O
118491,5,multiple,O
118491,5,tubular,O
118491,5,hypo-to-anechoic,O
118491,5,structures,O
118491,5,which,O
118491,5,could,O
118491,5,represent,O
118491,5,dilated,O
118491,5,ducts,O
118491,5,or,O
118491,5,less,O
118491,5,likely,O
118491,5,",",O
118491,5,thrombosed,O
118491,5,veins,O
118491,5,.,O
118491,5,No,O
118491,5,frank,O
118491,5,mass,O
118491,5,lesion,O
118491,5,is,O
118491,5,identified,O
118491,5,but,O
118491,5,assessment,O
118491,5,is,O
118491,5,limited,O
118491,5,due,O
118491,5,to,O
118491,5,the,O
118491,5,shrunken,O
118491,5,appearance,O
118491,5,of,O
118491,5,the,O
118491,5,liver,O
118491,5,.,O
118491,5,The,O
118491,5,spleen,O
118491,5,is,O
118491,5,within,O
118491,5,normal,O
118491,5,limits,O
118491,5,in,O
118491,5,size,O
118491,5,measuring,O
118491,5,10.7,O
118491,5,cm,O
118491,5,.,O
118491,5,.,O
118491,5,IMPRESSION,O
118491,5,:,O
118491,5,1,O
118491,5,.,O
118491,5,Patent,O
118491,5,TIPS,O
118491,5,with,O
118491,5,wall-to-wall,O
118491,5,flows,O
118491,5,and,O
118491,5,appropriate,O
118491,5,velocities,O
118491,5,as,O
118491,5,listed,O
118491,5,above,O
118491,5,.,O
118491,5,2,O
118491,5,.,O
118491,5,Shrunken,O
118491,5,cirrhotic,O
118491,5,liver,O
118491,5,without,O
118491,5,overt,O
118491,5,hepatic,O
118491,5,mass,O
118491,5,.,O
118491,5,Questionable,O
118491,5,biliary,O
118491,5,dilatation,O
118491,5,anterior,O
118491,5,to,O
118491,5,TIPS,O
118491,5,stent,O
118491,5,.,O
118491,5,[,O
118491,5,**5-29**,O
118491,5,],O
118491,5,CT,O
118491,5,A/P-,O
118491,5,IMPRESSION,O
118491,5,:,O
118491,5,1,O
118491,5,.,O
118491,5,Numerous,O
118491,5,noncalcified,O
118491,5,subcentimeter,O
118491,5,nonspecific,O
118491,5,pulmonary,O
118491,5,nodules,O
118491,5,.,O
118491,5,Comparison,O
118491,5,with,O
118491,5,prior,O
118491,5,CT,O
118491,5,scans,O
118491,5,if,O
118491,5,available,O
118491,5,is,O
118491,5,recommended,O
118491,5,to,O
118491,5,evaluate,O
118491,5,for,O
118491,5,stability,O
118491,5,.,O
118491,5,If,O
118491,5,no,O
118491,5,prior,O
118491,5,examinations,O
118491,5,are,O
118491,5,available,O
118491,5,for,O
118491,5,comparison,O
118491,5,",",O
118491,5,and,O
118491,5,the,O
118491,5,patient,O
118491,5,is,O
118491,5,a,O
118491,5,high,O
118491,5,risk,O
118491,5,patient,O
118491,5,i.e,O
118491,5,.,O
118491,5,is,O
118491,5,a,O
118491,5,smoker,O
118491,5,or,O
118491,5,has,O
118491,5,a,O
118491,5,known,O
118491,5,primary,O
118491,5,malignancy,O
118491,5,",",O
118491,5,a,O
118491,5,followup,O
118491,5,with,O
118491,5,CT,O
118491,5,of,O
118491,5,the,O
118491,5,chest,O
118491,5,in,O
118491,5,[,O
118491,5,**5-25**,O
118491,5,],O
118491,5,months,O
118491,5,is,O
118491,5,recommended,O
118491,5,.,O
118491,5,If,O
118491,5,the,O
118491,5,patient,O
118491,5,is,O
118491,5,at,O
118491,5,low,O
118491,5,risk,O
118491,5,i.e.,O
118491,5,",",O
118491,5,is,O
118491,5,not,O
118491,5,a,O
118491,5,smoker,O
118491,5,or,O
118491,5,has,O
118491,5,no,O
118491,5,known,O
118491,5,malignancy,O
118491,5,",",O
118491,5,followup,O
118491,5,with,O
118491,5,CT,O
118491,5,of,O
118491,5,the,O
118491,5,chest,O
118491,5,in,O
118491,5,twelve,O
118491,5,months,O
118491,5,is,O
118491,5,recommended,O
118491,5,.,O
118491,5,2,O
118491,5,.,O
118491,5,TIPS,O
118491,5,in,O
118491,5,the,O
118491,5,right,O
118491,5,hepatic,O
118491,5,lobe,O
118491,5,.,O
118491,5,3,O
118491,5,.,O
118491,5,Chronic,O
118491,5,occlusion,O
118491,5,of,O
118491,5,the,O
118491,5,left,O
118491,5,portal,O
118491,5,vein,O
118491,5,and,O
118491,5,posterior,O
118491,5,division,O
118491,5,of,O
118491,5,the,O
118491,5,right,O
118491,5,portal,O
118491,5,vein,O
118491,5,with,O
118491,5,corkscrew,O
118491,5,hepatic,O
118491,5,arteries,O
118491,5,which,O
118491,5,are,O
118491,5,patent,O
118491,5,.,O
118491,5,There,O
118491,5,is,O
118491,5,a,O
118491,5,tiny,O
118491,6,left,O
118491,6,hepatic,O
118491,6,artery,O
118491,6,off,O
118491,6,of,O
118491,6,the,O
118491,6,proper,O
118491,6,hepatic,O
118491,6,artery,O
118491,6,with,O
118491,6,an,O
118491,6,accessory,O
118491,6,branch,O
118491,6,off,O
118491,6,the,O
118491,6,left,O
118491,6,gastric,O
118491,6,artery,O
118491,6,.,O
118491,6,No,O
118491,6,suspicious,O
118491,6,hepatic,O
118491,6,lesions,O
118491,6,.,O
118491,6,4,O
118491,6,.,O
118491,6,Moderate,O
118491,6,intraabdominal,O
118491,6,and,O
118491,6,intrapelvic,O
118491,6,ascites,O
118491,6,with,O
118491,6,extensive,O
118491,6,intraabdominal,O
118491,6,varices,O
118491,6,as,O
118491,6,described,O
118491,6,consistent,O
118491,6,with,O
118491,6,portal,O
118491,6,hypertension,O
118491,6,.,O
118491,6,.,O
118491,6,ECHO,O
118491,6,(,O
118491,6,TTE,O
118491,6,),O
118491,6,[,O
118491,6,**2106-6-1**,O
118491,6,],O
118491,6,-,O
118491,6,Conclusions,O
118491,6,:,O
118491,6,The,O
118491,6,left,O
118491,6,atrium,O
118491,6,is,O
118491,6,mildly,O
118491,6,dilated,O
118491,6,.,O
118491,6,Left,O
118491,6,ventricular,O
118491,6,wall,O
118491,6,thicknesses,O
118491,6,are,O
118491,6,normal,O
118491,6,.,O
118491,6,The,O
118491,6,left,O
118491,6,ventricular,O
118491,6,cavity,O
118491,6,size,O
118491,6,is,O
118491,6,normal,O
118491,6,.,O
118491,6,Regional,O
118491,6,left,O
118491,6,ventricular,O
118491,6,wall,O
118491,6,motion,O
118491,6,is,O
118491,6,normal,O
118491,6,.,O
118491,6,Left,O
118491,6,ventricular,O
118491,6,systolic,O
118491,6,function,O
118491,6,is,O
118491,6,hyperdynamic,O
118491,6,(,O
118491,6,EF,O
118491,6,>,O
118491,6,75,O
118491,6,%,O
118491,6,),O
118491,6,.,O
118491,6,Right,O
118491,6,ventricular,O
118491,6,chamber,O
118491,6,size,O
118491,6,and,O
118491,6,free,O
118491,6,wall,O
118491,6,motion,O
118491,6,are,O
118491,6,normal,O
118491,6,.,O
118491,6,The,O
118491,6,aortic,O
118491,6,valve,O
118491,6,leaflets,O
118491,6,(,O
118491,6,3,O
118491,6,),O
118491,6,appear,O
118491,6,structurally,O
118491,6,normal,O
118491,6,with,O
118491,6,good,O
118491,6,leaflet,O
118491,6,excursion,O
118491,6,.,O
118491,6,There,O
118491,6,is,O
118491,6,no,O
118491,6,valvular,O
118491,6,aortic,O
118491,6,stenosis,O
118491,6,.,O
118491,6,The,O
118491,6,increased,O
118491,6,transaortic,O
118491,6,gradient,O
118491,6,is,O
118491,6,likely,O
118491,6,related,O
118491,6,to,O
118491,6,high,O
118491,6,cardiac,O
118491,6,output,O
118491,6,.,O
118491,6,Trace,O
118491,6,aortic,O
118491,6,regurgitation,O
118491,6,is,O
118491,6,seen,O
118491,6,.,O
118491,6,The,O
118491,6,mitral,O
118491,6,valve,O
118491,6,appears,O
118491,6,structurally,O
118491,6,normal,O
118491,6,with,O
118491,6,trivial,O
118491,6,mitral,O
118491,6,regurgitation,O
118491,6,.,O
118491,6,There,O
118491,6,is,O
118491,6,no,O
118491,6,mitral,O
118491,6,valve,O
118491,6,prolapse,O
118491,6,.,O
118491,6,Mild,O
118491,6,(,O
118491,6,1+,O
118491,6,),O
118491,6,mitral,O
118491,6,regurgitation,O
118491,6,is,O
118491,6,seen,O
118491,6,.,O
118491,6,The,O
118491,6,estimated,O
118491,6,pulmonary,O
118491,6,artery,O
118491,6,systolic,O
118491,6,pressure,O
118491,6,is,O
118491,6,normal,O
118491,6,.,O
118491,6,There,O
118491,6,is,O
118491,6,no,O
118491,6,pericardial,O
118491,6,effusion,O
118491,6,.,O
118491,6,.,O
118491,6,IMPRESSION,O
118491,6,:,O
118491,6,Normal/hyperdynamic,O
118491,6,biventricular,O
118491,6,systolic,O
118491,6,function,O
118491,6,.,O
118491,6,Mild,O
118491,6,mitral,O
118491,6,regurgitation,O
118491,6,.,O
118491,6,Trivial,O
118491,6,aortic,O
118491,6,regurgitation,O
118491,6,.,O
118491,6,.,O
118491,6,Portable,O
118491,6,CXR,O
118491,6,[,O
118491,6,**6-4**,O
118491,6,],O
118491,6,:,O
118491,6,Cardiomediastinal,O
118491,6,contour,O
118491,6,is,O
118491,6,unchanged,O
118491,6,.,O
118491,6,NG,O
118491,6,tube,O
118491,6,tip,O
118491,6,is,O
118491,6,below,O
118491,6,the,O
118491,6,diaphragm,O
118491,6,out,O
118491,6,of,O
118491,6,view,O
118491,6,.,O
118491,6,Right,O
118491,6,PICC,O
118491,6,line,O
118491,6,tip,O
118491,6,is,O
118491,6,in,O
118491,6,the,O
118491,6,mid,O
118491,6,SVC,O
118491,6,.,O
118491,6,There,O
118491,6,is,O
118491,6,no,O
118491,6,pneumothorax,O
118491,6,.,O
118491,6,New,O
118491,6,ill-defined,O
118491,6,opacity,O
118491,6,in,O
118491,6,the,O
118491,6,left,O
118491,6,lower,O
118491,6,lobe,O
118491,6,in,O
118491,6,the,O
118491,6,retrocardiac,O
118491,6,area,O
118491,6,is,O
118491,6,consistent,O
118491,6,with,O
118491,6,atelectasis,O
118491,6,and/or,O
118491,6,area,O
118491,6,of,O
118491,6,aspiration,O
118491,6,Small,O
118491,6,left,O
118491,6,pleural,O
118491,6,effusion,O
118491,6,is,O
118491,6,also,O
118491,6,new,O
118491,6,.,O
118491,6,.,O
118491,6,CT,O
118491,6,Chest,O
118491,6,[,O
118491,6,**6-8**,O
118491,6,],O
118491,6,:,O
118491,6,IMPRESSION,O
118491,6,:,O
118491,6,1,O
118491,6,.,O
118491,6,Interim,O
118491,6,improvement,O
118491,6,in,O
118491,6,diffuse,O
118491,6,predominantly,O
118491,6,peribronchiolar,O
118491,6,nodular,O
118491,6,opacities,O
118491,6,",",O
118491,6,though,O
118491,6,numerous,O
118491,6,nodular,O
118491,6,opacities,O
118491,6,persist,O
118491,6,on,O
118491,6,the,O
118491,6,current,O
118491,6,study,O
118491,7,.,O
118491,7,The,O
118491,7,coalescing,O
118491,7,airspace,O
118491,7,disease,O
118491,7,adjacent,O
118491,7,to,O
118491,7,the,O
118491,7,minor,O
118491,7,fissure,O
118491,7,appears,O
118491,7,much,O
118491,7,improved,O
118491,7,.,O
118491,7,Given,O
118491,7,the,O
118491,7,improved,O
118491,7,appearance,O
118491,7,over,O
118491,7,the,O
118491,7,short,O
118491,7,interval,O
118491,7,",",O
118491,7,an,O
118491,7,infectious,O
118491,7,process,O
118491,7,is,O
118491,7,considered,O
118491,7,likely,O
118491,7,.,O
118491,7,Eventual,O
118491,7,CT,O
118491,7,followup,O
118491,7,(,O
118491,7,three,O
118491,7,months,O
118491,7,),O
118491,7,is,O
118491,7,recommended,O
118491,7,after,O
118491,7,treatment,O
118491,7,.,O
118491,7,2,O
118491,7,.,O
118491,7,Small,O
118491,7,bilateral,O
118491,7,pleural,O
118491,7,effusions,O
118491,7,and,O
118491,7,moderate-to-large,O
118491,7,ascites,O
118491,7,as,O
118491,7,well,O
118491,7,as,O
118491,7,subcutaneous,O
118491,7,edema,O
118491,7,are,O
118491,7,unchanged,O
118491,7,from,O
118491,7,the,O
118491,7,prior,O
118491,7,exam,O
118491,7,.,O
118491,7,.,O
118491,7,Abdominal,O
118491,7,U/S,O
118491,7,[,O
118491,7,**6-11**,O
118491,7,],O
118491,7,:,O
118491,7,IMPRESSION,O
118491,7,:,O
118491,7,1,O
118491,7,.,O
118491,7,Moderate,O
118491,7,to,O
118491,7,large,O
118491,7,amount,O
118491,7,of,O
118491,7,ascites,O
118491,7,.,O
118491,7,A,O
118491,7,spot,O
118491,7,was,O
118491,7,marked,O
118491,7,for,O
118491,7,paracentesis,O
118491,7,to,O
118491,7,be,O
118491,7,performed,O
118491,7,by,O
118491,7,the,O
118491,7,clinical,O
118491,7,service,O
118491,7,.,O
118491,7,2,O
118491,7,.,O
118491,7,_____,O
118491,7,TIPS,O
118491,7,unchanged,O
118491,7,from,O
118491,7,the,O
118491,7,prior,O
118491,7,studies,O
118491,7,.,O
118491,7,3,O
118491,7,.,O
118491,7,Cirrhotic,O
118491,7,liver,O
118491,7,.,O
118491,7,No,O
118491,7,focal,O
118491,7,lesions,O
118491,7,identified,O
118491,7,.,O
118491,7,.,O
118491,7,Portable,O
118491,7,CXR,O
118491,7,[,O
118491,7,**6-14**,O
118491,7,],O
118491,7,:,O
118491,7,IMPRESSION,O
118491,7,:,O
118491,7,AP,O
118491,7,chest,O
118491,7,compared,O
118491,7,to,O
118491,7,[,O
118491,7,**2106-6-12**,O
118491,7,],O
118491,7,:,O
118491,7,Pulmonary,O
118491,7,vascular,O
118491,7,congestion,O
118491,7,has,O
118491,7,worsened,O
118491,7,and,O
118491,7,new,O
118491,7,opacification,O
118491,7,at,O
118491,7,the,O
118491,7,lung,O
118491,7,bases,O
118491,7,is,O
118491,7,probably,O
118491,7,a,O
118491,7,combination,O
118491,7,of,O
118491,7,atelectasis,O
118491,7,and,O
118491,7,mild,O
118491,7,edema,O
118491,7,.,O
118491,7,Pleural,O
118491,7,effusion,O
118491,7,is,O
118491,7,small,O
118491,7,",",O
118491,7,on,O
118491,7,the,O
118491,7,left,O
118491,7,",",O
118491,7,unchanged,O
118491,7,acutely,O
118491,7,.,O
118491,7,Heart,O
118491,7,size,O
118491,7,is,O
118491,7,top,O
118491,7,normal,O
118491,7,.,O
118491,7,Left,O
118491,7,PIC,O
118491,7,catheter,O
118491,7,ends,O
118491,7,at,O
118491,7,the,O
118491,7,superior,O
118491,7,cavoatrial,O
118491,7,junction,O
118491,7,.,O
118491,7,Esophageal,O
118491,7,tube,O
118491,7,and,O
118491,7,right,O
118491,7,PIC,O
118491,7,line,O
118491,7,have,O
118491,7,been,O
118491,7,removed,O
118491,7,.,O
118491,7,.,O
118491,7,ECHO,O
118491,7,[,O
118491,7,**6-15**,O
118491,7,],O
118491,7,:,O
118491,7,Conclusions,O
118491,7,:,O
118491,7,The,O
118491,7,left,O
118491,7,atrium,O
118491,7,is,O
118491,7,elongated,O
118491,7,.,O
118491,7,Left,O
118491,7,ventricular,O
118491,7,wall,O
118491,7,thicknesses,O
118491,7,are,O
118491,7,normal,O
118491,7,.,O
118491,7,The,O
118491,7,left,O
118491,7,ventricular,O
118491,7,cavity,O
118491,7,size,O
118491,7,is,O
118491,7,normal,O
118491,7,.,O
118491,7,Left,O
118491,7,ventricular,O
118491,7,systolic,O
118491,7,function,O
118491,7,is,O
118491,7,hyperdynamic,O
118491,7,(,O
118491,7,EF,O
118491,7,>,O
118491,7,75,O
118491,7,%,O
118491,7,),O
118491,7,.,O
118491,7,There,O
118491,7,is,O
118491,7,no,O
118491,7,ventricular,O
118491,7,septal,O
118491,7,defect,O
118491,7,.,O
118491,7,Right,O
118491,7,ventricular,O
118491,7,chamber,O
118491,7,size,O
118491,7,and,O
118491,7,free,O
118491,7,wall,O
118491,7,motion,O
118491,7,are,O
118491,7,normal,O
118491,7,.,O
118491,7,The,O
118491,7,aortic,O
118491,7,valve,O
118491,7,leaflets,O
118491,7,(,O
118491,7,3,O
118491,7,),O
118491,7,appear,O
118491,7,structurally,O
118491,7,normal,O
118491,7,with,O
118491,7,good,O
118491,7,leaflet,O
118491,7,excursion,O
118491,7,.,O
118491,7,No,O
118491,7,masses,O
118491,7,or,O
118491,7,vegetations,O
118491,7,are,O
118491,7,seen,O
118491,7,on,O
118491,7,the,O
118491,7,aortic,O
118491,7,valve,O
118491,7,.,O
118491,7,There,O
118491,7,is,O
118491,7,no,O
118491,7,valvular,O
118491,7,aortic,O
118491,7,stenosis,O
118491,7,.,O
118491,7,The,O
118491,7,increased,O
118491,7,transaortic,O
118491,7,gradient,O
118491,7,is,O
118491,7,likely,O
118491,7,related,O
118491,7,to,O
118491,7,high,O
118491,7,cardiac,O
118491,7,output,O
118491,7,.,O
118491,7,Mild,O
118491,7,(,O
118491,7,1+,O
118491,8,),O
118491,8,aortic,O
118491,8,regurgitation,O
118491,8,is,O
118491,8,seen,O
118491,8,.,O
118491,8,The,O
118491,8,mitral,O
118491,8,valve,O
118491,8,leaflets,O
118491,8,are,O
118491,8,mildly,O
118491,8,thickened,O
118491,8,.,O
118491,8,There,O
118491,8,is,O
118491,8,no,O
118491,8,mitral,O
118491,8,valve,O
118491,8,prolapse,O
118491,8,.,O
118491,8,No,O
118491,8,mass,O
118491,8,or,O
118491,8,vegetation,O
118491,8,is,O
118491,8,seen,O
118491,8,on,O
118491,8,the,O
118491,8,mitral,O
118491,8,valve,O
118491,8,.,O
118491,8,Trivial,O
118491,8,mitral,O
118491,8,regurgitation,O
118491,8,is,O
118491,8,seen,O
118491,8,.,O
118491,8,There,O
118491,8,is,O
118491,8,moderate,O
118491,8,pulmonary,O
118491,8,artery,O
118491,8,systolic,O
118491,8,hypertension,O
118491,8,.,O
118491,8,No,O
118491,8,vegetation/mass,O
118491,8,is,O
118491,8,seen,O
118491,8,on,O
118491,8,the,O
118491,8,pulmonic,O
118491,8,valve,O
118491,8,.,O
118491,8,There,O
118491,8,is,O
118491,8,no,O
118491,8,pericardial,O
118491,8,effusion,O
118491,8,.,O
118491,8,.,O
118491,8,Compared,O
118491,8,with,O
118491,8,the,O
118491,8,findings,O
118491,8,of,O
118491,8,the,O
118491,8,prior,O
118491,8,study,O
118491,8,(,O
118491,8,images,O
118491,8,reviewed,O
118491,8,),O
118491,8,of,O
118491,8,[,O
118491,8,**2106-6-1**,O
118491,8,],O
118491,8,",",O
118491,8,the,O
118491,8,tricuspid,O
118491,8,regurgitation,O
118491,8,is,O
118491,8,somewhat,O
118491,8,increased,O
118491,8,.,O
118491,8,.,O
118491,8,If,O
118491,8,clinically,O
118491,8,suggested,O
118491,8,",",O
118491,8,the,O
118491,8,absence,O
118491,8,of,O
118491,8,a,O
118491,8,vegetation,O
118491,8,by,O
118491,8,2D,O
118491,8,echocardiography,O
118491,8,does,O
118491,8,not,O
118491,8,exclude,O
118491,8,endocarditis,O
118491,8,.,O
118491,8,.,O
118491,8,[,O
118491,8,**6-16**,O
118491,8,],O
118491,8,Chest,O
118491,8,CT,O
118491,8,FINDINGS,O
118491,8,:,O
118491,8,Since,O
118491,8,the,O
118491,8,prior,O
118491,8,study,O
118491,8,there,O
118491,8,has,O
118491,8,been,O
118491,8,marked,O
118491,8,worsening,O
118491,8,of,O
118491,8,the,O
118491,8,alveolar,O
118491,8,opacities,O
118491,8,involving,O
118491,8,both,O
118491,8,lungs,O
118491,8,",",O
118491,8,predominantly,O
118491,8,in,O
118491,8,the,O
118491,8,upper,O
118491,8,zones,O
118491,8,.,O
118491,8,The,O
118491,8,periphery,O
118491,8,of,O
118491,8,the,O
118491,8,lungs,O
118491,8,is,O
118491,8,relatively,O
118491,8,spared,O
118491,8,.,O
118491,8,There,O
118491,8,are,O
118491,8,small,O
118491,8,bilateral,O
118491,8,pleural,O
118491,8,effusions,O
118491,8,.,O
118491,8,The,O
118491,8,heart,O
118491,8,size,O
118491,8,appears,O
118491,8,slightly,O
118491,8,enlarged,O
118491,8,.,O
118491,8,There,O
118491,8,is,O
118491,8,no,O
118491,8,pericardial,O
118491,8,effusion,O
118491,8,.,O
118491,8,There,O
118491,8,are,O
118491,8,borderline,O
118491,8,lymph,O
118491,8,nodes,O
118491,8,in,O
118491,8,the,O
118491,8,paratracheal,O
118491,8,region,O
118491,8,measuring,O
118491,8,up,O
118491,8,to,O
118491,8,9,O
118491,8,mm,O
118491,8,in,O
118491,8,short,O
118491,8,axis,O
118491,8,.,O
118491,8,The,O
118491,8,central,O
118491,8,airways,O
118491,8,are,O
118491,8,patent,O
118491,8,without,O
118491,8,endoluminal,O
118491,8,lesions,O
118491,8,.,O
118491,8,A,O
118491,8,left-sided,O
118491,8,PICC,O
118491,8,is,O
118491,8,seen,O
118491,8,extending,O
118491,8,into,O
118491,8,the,O
118491,8,superior,O
118491,8,vena,O
118491,8,cava,O
118491,8,.,O
118491,8,.,O
118491,8,In,O
118491,8,the,O
118491,8,visualized,O
118491,8,upper,O
118491,8,abdomen,O
118491,8,again,O
118491,8,seen,O
118491,8,is,O
118491,8,a,O
118491,8,cirrhotic,O
118491,8,liver,O
118491,8,with,O
118491,8,the,O
118491,8,TIPS,O
118491,8,shunt,O
118491,8,in,O
118491,8,place,O
118491,8,.,O
118491,8,There,O
118491,8,is,O
118491,8,a,O
118491,8,large,O
118491,8,amount,O
118491,8,of,O
118491,8,ascites,O
118491,8,noted,O
118491,8,.,O
118491,8,Coils,O
118491,8,are,O
118491,8,noted,O
118491,8,in,O
118491,8,the,O
118491,8,region,O
118491,8,of,O
118491,8,the,O
118491,8,splenic,O
118491,8,vessels,O
118491,8,.,O
118491,8,The,O
118491,8,osseous,O
118491,8,structures,O
118491,8,appear,O
118491,8,unremarkable,O
118491,8,.,O
118491,8,.,O
118491,8,IMPRESSION,O
118491,8,:,O
118491,8,1,O
118491,8,.,O
118491,8,Marked,O
118491,8,worsening,O
118491,8,of,O
118491,8,bilateral,O
118491,8,extensive,O
118491,8,alveolar,O
118491,8,opacities,O
118491,8,particularly,O
118491,8,centrally,O
118491,8,.,O
118491,8,The,O
118491,8,rapidity,O
118491,8,of,O
118491,8,development,O
118491,8,and,O
118491,8,distribution,O
118491,8,is,O
118491,8,most,O
118491,8,concerning,O
118491,8,for,O
118491,8,pulmonary,O
118491,8,edema,O
118491,8,",",O
118491,8,however,O
118491,8,",",O
118491,8,atypical,O
118491,8,infection,O
118491,8,or,O
118491,8,less,O
118491,8,likely,O
118491,8,pulmonary,O
118491,8,hemorrhage,O
118491,8,can,O
118491,8,not,O
118491,8,be,O
118491,8,excluded,O
118491,8,.,O
118491,8,Small,O
118491,8,bilateral,O
118491,8,pleural,O
118491,8,effusions,O
118491,8,.,O
118491,8,2,O
118491,8,.,O
118491,8,Cirrhotic,O
118491,8,liver,O
118491,8,with,O
118491,9,a,O
118491,9,moderate,O
118491,9,amount,O
118491,9,of,O
118491,9,ascites,O
118491,9,and,O
118491,9,TIPS,O
118491,9,shunt,O
118491,9,in,O
118491,9,place,O
118491,9,.,O
118491,9,.,O
118491,9,OTHER,O
118491,9,STUDIES,O
118491,9,:,O
118491,9,==============,O
118491,9,EGD,O
118491,9,[,O
118491,9,**2106-6-2**,O
118491,9,],O
118491,9,-,O
118491,9,Grade,O
118491,9,1,O
118491,9,esophageal,O
118491,9,varices,O
118491,9,A,O
118491,9,trans-endoscopic,O
118491,9,NJ,O
118491,9,feeding,O
118491,9,tube,O
118491,9,(,O
118491,9,8,O
118491,9,fr,O
118491,9,),O
118491,9,was,O
118491,9,placed,O
118491,9,to,O
118491,9,120,O
118491,9,cm,O
118491,9,.,O
118491,9,Otherwise,O
118491,9,normal,O
118491,9,EGD,O
118491,9,to,O
118491,9,second,O
118491,9,part,O
118491,9,of,O
118491,9,duodenum,O
118491,9,.,O
118491,9,Brief,O
118491,9,Hospital,O
118491,9,Course,O
118491,9,:,O
118491,9,45,O
118491,9,yo,O
118491,9,female,O
118491,9,with,O
118491,9,ESLD,O
118491,9,[,O
118491,9,**1-15**,O
118491,9,],O
118491,9,EtOH,O
118491,9,cirrhosis,O
118491,9,s/p,O
118491,9,TIPS,O
118491,9,who,O
118491,9,presented,O
118491,9,from,O
118491,9,OSH,O
118491,9,for,O
118491,9,liver,O
118491,9,transplant,O
118491,9,evaluation,O
118491,9,",",O
118491,9,recent,O
118491,9,severe,O
118491,9,bleeding,O
118491,9,",",O
118491,9,who,O
118491,9,developed,O
118491,9,sepsis,O
118491,9,",",O
118491,9,DIC,O
118491,9,",",O
118491,9,and,O
118491,9,multiorgan,O
118491,9,failure,O
118491,9,.,O
118491,9,A,O
118491,9,brief,O
118491,9,hospital,O
118491,9,course,O
118491,9,by,O
118491,9,problem,O
118491,9,is,O
118491,9,outlined,O
118491,9,below,O
118491,9,:,O
118491,9,.,O
118491,9,#,O
118491,9,Sepsis,B-Reason
118491,9,/,O
118491,9,DIC,B-Reason
118491,9,:,O
118491,9,The,O
118491,9,patient,O
118491,9,required,O
118491,9,multiple,O
118491,9,vasopressors,B-Drug
118491,9,to,O
118491,9,maintain,O
118491,9,SvO2,O
118491,9,>,O
118491,9,70,O
118491,9,and,O
118491,9,MAP,O
118491,9,>,O
118491,9,60s,O
118491,9,.,O
118491,9,Lactate,O
118491,9,continued,O
118491,9,to,O
118491,9,rise,O
118491,9,and,O
118491,9,she,O
118491,9,became,O
118491,9,progressively,O
118491,9,acidotic,O
118491,9,.,O
118491,9,End,O
118491,9,organ,O
118491,9,hypoperfusion,O
118491,9,was,O
118491,9,demonstrated,O
118491,9,by,O
118491,9,anuria,O
118491,9,.,O
118491,9,She,O
118491,9,was,O
118491,9,treated,O
118491,9,broadly,O
118491,9,with,O
118491,9,antibiotics,B-Drug
118491,9,and,O
118491,9,aggressively,O
118491,9,transfused,O
118491,9,with,O
118491,9,blood,B-Drug
118491,9,products,I-Drug
118491,9,and,O
118491,9,albumin,B-Drug
118491,9,for,O
118491,9,intravascular,B-Reason
118491,9,volume,I-Reason
118491,9,support,I-Reason
118491,9,and,O
118491,9,to,O
118491,9,correct,B-Reason
118491,9,her,I-Reason
118491,9,underlying,I-Reason
118491,9,coagulopathy,I-Reason
118491,9,.,O
118491,9,HCO3,B-Drug
118491,9,was,O
118491,9,utilized,O
118491,9,prn,O
118491,9,given,O
118491,9,worsening,O
118491,9,acidosis,B-Reason
118491,9,.,O
118491,9,The,O
118491,9,patient,O
118491,9,was,O
118491,9,made,O
118491,9,CMO,O
118491,9,after,O
118491,9,an,O
118491,9,extensive,O
118491,9,family,O
118491,9,discussion,O
118491,9,regarding,O
118491,9,her,O
118491,9,poor,O
118491,9,prognosis,O
118491,9,and,O
118491,9,she,O
118491,9,rapidly,O
118491,9,expired,O
118491,9,after,O
118491,9,removal,O
118491,9,of,O
118491,9,vasopressors,B-Drug
118491,9,and,O
118491,9,respiratory,O
118491,9,support,O
118491,9,.,O
118491,9,.,O
118491,9,#,O
118491,9,Respiratory,O
118491,9,Failure,O
118491,9,:,O
118491,9,Progressively,O
118491,9,worsening,O
118491,9,bilateral,O
118491,9,lung,O
118491,9,infiltrates,O
118491,9,resulting,O
118491,9,in,O
118491,9,hypoxia,O
118491,9,requiring,O
118491,9,intubation,O
118491,9,.,O
118491,9,Differential,O
118491,9,included,O
118491,9,DAH,O
118491,9,given,O
118491,9,coagulopathy,O
118491,9,",",O
118491,9,infection,B-ADE
118491,9,(,O
118491,9,e.g,O
118491,9,.,O
118491,9,PCP/fungal,O
118491,9,given,O
118491,9,recent,O
118491,9,course,O
118491,9,of,O
118491,9,steroids,B-Drug
118491,9,),O
118491,9,",",O
118491,9,or,O
118491,9,TRALI,O
118491,9,(,O
118491,9,though,O
118491,9,unlikely,O
118491,9,),O
118491,9,.,O
118491,9,She,O
118491,9,was,O
118491,9,afebrile,O
118491,9,with,O
118491,9,rapidly,O
118491,9,progressive,O
118491,9,leukocytosis,O
118491,9,.,O
118491,9,The,O
118491,9,patient,O
118491,9,was,O
118491,9,treated,O
118491,9,with,O
118491,9,steroids,B-Drug
118491,9,and,O
118491,9,bactrim,B-Drug
118491,9,for,O
118491,9,PCP,B-Reason
118491,9,",",O
118491,9,[,O
118491,9,**Name10,O
118491,9,(,O
118491,9,NameIs,O
118491,9,),O
118491,9,74369**,O
118491,9,],O
118491,9,for,O
118491,9,fungal,O
118491,9,coverage,O
118491,9,",",O
118491,9,and,O
118491,9,levaquin,B-Drug
118491,9,to,O
118491,9,cover,O
118491,9,mycoplasma,B-Reason
118491,9,",",O
118491,9,and,O
118491,9,flagyl,B-Drug
118491,9,for,O
118491,9,anaerobic,B-Reason
118491,9,coverage,I-Reason
118491,9,.,O
118491,9,Given,O
118491,9,worsening,O
118491,9,infiltrates,O
118491,9,and,O
118491,9,P/F,O
118491,9,ratio,O
118491,9,suggestive,O
118491,9,of,O
118491,9,ARDS,O
118491,9,",",O
118491,9,she,O
118491,9,was,O
118491,9,ventilated,O
118491,9,on,O
118491,9,ARDSnet,O
118491,9,protocol,O
118491,9,to,O
118491,9,minimize,O
118491,9,barotrauma,O
118491,9,and,O
118491,9,allowed,O
118491,10,permissive,O
118491,10,hypercapnea,O
118491,10,.,O
118491,10,.,O
118491,10,#,O
118491,10,Acute,O
118491,10,renal,O
118491,10,failure,O
118491,10,:,O
118491,10,Cr,O
118491,10,progressively,O
118491,10,worsened,O
118491,10,in,O
118491,10,the,O
118491,10,setting,O
118491,10,of,O
118491,10,sepsis,O
118491,10,and,O
118491,10,the,O
118491,10,patient,O
118491,10,became,O
118491,10,anuric,O
118491,10,.,O
118491,10,Differential,O
118491,10,included,O
118491,10,HRS,O
118491,10,",",O
118491,10,ATN,O
118491,10,[,O
118491,10,**1-15**,O
118491,10,],O
118491,10,renal,O
118491,10,hypoperfusion,O
118491,10,",",O
118491,10,prerenal,O
118491,10,[,O
118491,10,**1-15**,O
118491,10,],O
118491,10,hypoalbuminemia,O
118491,10,and,O
118491,10,3rd,O
118491,10,spacing,O
118491,10,.,O
118491,10,She,O
118491,10,was,O
118491,10,unable,O
118491,10,to,O
118491,10,take,O
118491,10,po,O
118491,10,octreotide,B-Drug
118491,10,",",O
118491,10,midodrine,B-Drug
118491,10,due,O
118491,10,to,O
118491,10,increased,B-ADE
118491,10,GI,I-ADE
118491,10,secretions,I-ADE
118491,10,and,O
118491,10,poor,O
118491,10,absorption,O
118491,10,.,O
118491,10,Attempted,O
118491,10,to,O
118491,10,increased,O
118491,10,intravascular,B-Reason
118491,10,volume,I-Reason
118491,10,with,O
118491,10,albumin,B-Drug
118491,10,and,O
118491,10,blood,B-Drug
118491,10,products,I-Drug
118491,10,.,I-Drug
118491,10,Pressors,O
118491,10,were,O
118491,10,utilized,O
118491,10,to,O
118491,10,maintain,O
118491,10,renal,B-Reason
118491,10,perfusion,I-Reason
118491,10,.,O
118491,10,The,O
118491,10,patient,O
118491,10,developed,O
118491,10,a,O
118491,10,severe,B-Reason
118491,10,lactic,I-Reason
118491,10,acid,I-Reason
118491,10,metabolic,I-Reason
118491,10,acidosis,I-Reason
118491,10,due,O
118491,10,to,O
118491,10,tissue,O
118491,10,hypoxia,O
118491,10,requiring,O
118491,10,HCO3,B-Drug
118491,10,pushes,O
118491,10,.,O
118491,10,.,O
118491,10,#,O
118491,10,ETOH,O
118491,10,Cirrhosis,O
118491,10,:,O
118491,10,Decompensated,O
118491,10,liver,O
118491,10,disease,O
118491,10,s/p,O
118491,10,TIPS,O
118491,10,",",O
118491,10,with,O
118491,10,hepatic,O
118491,10,encephalopathy,O
118491,10,",",O
118491,10,coagluapathy,O
118491,10,",",O
118491,10,elevated,O
118491,10,Tbili,O
118491,10,",",O
118491,10,hyponatremia,O
118491,10,.,O
118491,10,On,O
118491,10,admission,O
118491,10,",",O
118491,10,aldactone,B-Drug
118491,10,held,O
118491,10,given,O
118491,10,hyponatremia,B-ADE
118491,10,and,O
118491,10,hypotension,B-ADE
118491,10,.,O
118491,10,Lasix,B-Drug
118491,10,held,O
118491,10,given,O
118491,10,auto-immune,B-ADE
118491,10,hemolytic,I-ADE
118491,10,anemia,I-ADE
118491,10,.,O
118491,10,She,O
118491,10,was,O
118491,10,given,O
118491,10,lactulose,B-Drug
118491,10,and,O
118491,10,rifaxamin,B-Drug
118491,10,for,O
118491,10,hepatic,B-Reason
118491,10,encephalopathy,I-Reason
118491,10,.,O
118491,10,Ultrasound,O
118491,10,perfomed,O
118491,10,on,O
118491,10,admission,O
118491,10,and,O
118491,10,showed,O
118491,10,patent,O
118491,10,TIPS,O
118491,10,",",O
118491,10,cirrhotic,O
118491,10,liver,O
118491,10,",",O
118491,10,no,O
118491,10,hepatoma,O
118491,10,.,O
118491,10,Diagnostic,O
118491,10,paracentesis,O
118491,10,was,O
118491,10,performed,O
118491,10,",",O
118491,10,and,O
118491,10,was,O
118491,10,negative,O
118491,10,for,O
118491,10,SBP,O
118491,10,.,O
118491,10,.,O
118491,10,During,O
118491,10,hospitalization,O
118491,10,",",O
118491,10,she,O
118491,10,was,O
118491,10,evaluated,O
118491,10,for,O
118491,10,liver,O
118491,10,transplant,O
118491,10,",",O
118491,10,and,O
118491,10,was,O
118491,10,transiently,O
118491,10,placed,O
118491,10,on,O
118491,10,the,O
118491,10,transplant,O
118491,10,list,O
118491,10,but,O
118491,10,was,O
118491,10,removed,O
118491,10,after,O
118491,10,becoming,O
118491,10,septic,O
118491,10,.,O
118491,10,TTE,O
118491,10,showed,O
118491,10,a,O
118491,10,hyperdynamic,O
118491,10,EF,O
118491,10,",",O
118491,10,with,O
118491,10,no,O
118491,10,pulmonary,O
118491,10,hypertension,O
118491,10,or,O
118491,10,significant,O
118491,10,valvular,O
118491,10,disease,O
118491,10,.,O
118491,10,Liver,O
118491,10,CT,O
118491,10,completed,O
118491,10,.,O
118491,10,PFT,O
118491,10,'s,O
118491,10,performed,O
118491,10,",",O
118491,10,with,O
118491,10,noted,O
118491,10,mild,O
118491,10,diffusion,O
118491,10,abnormality,O
118491,10,.,O
118491,10,Chest,O
118491,10,CT,O
118491,10,demonstrated,O
118491,10,pulmonary,O
118491,10,nodules,O
118491,10,(,O
118491,10,see,O
118491,10,below,O
118491,10,),O
118491,10,which,O
118491,10,were,O
118491,10,stable,O
118491,10,on,O
118491,10,repeat,O
118491,10,CT,O
118491,10,chest,O
118491,10,one,O
118491,10,week,O
118491,10,later,O
118491,10,.,O
118491,10,Chest,O
118491,10,CT,O
118491,10,from,O
118491,10,[,O
118491,10,**2106-6-16**,O
118491,10,],O
118491,10,showed,O
118491,10,marked,O
118491,10,worsening,O
118491,10,(,O
118491,10,see,O
118491,10,below,O
118491,10,),O
118491,10,.,O
118491,10,.,O
118491,10,Hospitalization,O
118491,10,was,O
118491,10,complicated,O
118491,10,by,O
118491,10,hepatic,O
118491,10,encephalopathy,O
118491,10,",",O
118491,10,hyponatremia,O
118491,10,and,O
118491,10,hepatorenal,O
118491,10,syndrome,O
118491,10,.,O
118491,10,HRS,B-Reason
118491,10,improved,O
118491,10,after,O
118491,10,midodrine,B-Drug
118491,10,and,O
118491,10,octreotide,B-Drug
118491,10,",",O
118491,10,and,O
118491,10,albumin,B-Drug
118491,10,steadied,O
118491,10,hyponatremia,B-Reason
118491,10,near,O
118491,10,baseline,O
118491,10,of,O
118491,10,127-129,O
118491,10,.,O
118491,10,She,O
118491,10,was,O
118491,10,fluid,O
118491,10,restricted,O
118491,10,",",O
118491,10,but,O
118491,10,continued,O
118491,10,to,O
118491,10,have,O
118491,10,worsening,O
118491,11,peripheral,O
118491,11,edema,O
118491,11,;,O
118491,11,diuretics,O
118491,11,were,O
118491,11,held,O
118491,11,given,O
118491,11,her,O
118491,11,recently,O
118491,11,diagnosed,O
118491,11,AIHA,B-ADE
118491,11,[,O
118491,11,**1-15**,O
118491,11,],O
118491,11,lasix,B-Drug
118491,11,.,O
118491,11,.,O
118491,11,#,O
118491,11,Arrhythmia,O
118491,11,:,O
118491,11,The,O
118491,11,patient,O
118491,11,had,O
118491,11,two,O
118491,11,asymptomatic,O
118491,11,episodes,O
118491,11,of,O
118491,11,stable,O
118491,11,Vtach,O
118491,11,on,O
118491,11,the,O
118491,11,floor,O
118491,11,.,O
118491,11,On,O
118491,11,[,O
118491,11,**2106-6-16**,O
118491,11,],O
118491,11,",",O
118491,11,pt,O
118491,11,developed,O
118491,11,atrial,O
118491,11,fibrillation,O
118491,11,to,O
118491,11,160,O
118491,11,'s,O
118491,11,.,O
118491,11,She,O
118491,11,was,O
118491,11,converted,O
118491,11,with,O
118491,11,lopressor,B-Drug
118491,11,and,O
118491,11,diltiazam,B-Drug
118491,11,",",O
118491,11,but,O
118491,11,then,O
118491,11,reverted,O
118491,11,to,O
118491,11,Afib/flutter,B-Reason
118491,11,rate-controlled,I-Reason
118491,11,on,O
118491,11,diltiazem,B-Drug
118491,11,.,O
118491,11,On,O
118491,11,transfer,O
118491,11,to,O
118491,11,the,O
118491,11,MICU,O
118491,11,",",O
118491,11,she,O
118491,11,had,O
118491,11,bursts,O
118491,11,of,O
118491,11,atrial,O
118491,11,flutter,O
118491,11,with,O
118491,11,variable,O
118491,11,block,O
118491,11,and,O
118491,11,rate-dependent,O
118491,11,bundle,O
118491,11,branch,O
118491,11,block,O
118491,11,.,O
118491,11,She,O
118491,11,remained,O
118491,11,asymptomatic,O
118491,11,but,O
118491,11,nodal,O
118491,11,agents,O
118491,11,were,O
118491,11,held,O
118491,11,given,O
118491,11,hypotension,O
118491,11,.,O
118491,11,.,O
118491,11,#,O
118491,11,Leukocytosis,O
118491,11,:,O
118491,11,Initially,O
118491,11,with,O
118491,11,nosocomial,O
118491,11,pneumonia,O
118491,11,at,O
118491,11,outside,O
118491,11,hospital,O
118491,11,treated,O
118491,11,with,O
118491,11,a,O
118491,11,course,O
118491,11,of,O
118491,11,IV,O
118491,11,antibiotics,B-Drug
118491,11,.,O
118491,11,Upon,O
118491,11,admission,O
118491,11,to,O
118491,11,[,O
118491,11,**Hospital1,O
118491,11,18**,O
118491,11,],O
118491,11,",",O
118491,11,no,O
118491,11,infectious,O
118491,11,etiology,O
118491,11,was,O
118491,11,found,O
118491,11,",",O
118491,11,with,O
118491,11,negative,O
118491,11,blood,O
118491,11,",",O
118491,11,urine,O
118491,11,and,O
118491,11,stool,O
118491,11,cultures,O
118491,11,.,O
118491,11,Although,O
118491,11,pulmonary,O
118491,11,nodules,O
118491,11,were,O
118491,11,seen,O
118491,11,on,O
118491,11,chest,O
118491,11,CT,O
118491,11,",",O
118491,11,this,O
118491,11,was,O
118491,11,not,O
118491,11,felt,O
118491,11,to,O
118491,11,represent,O
118491,11,an,O
118491,11,acute,O
118491,11,infectious,O
118491,11,process,O
118491,11,given,O
118491,11,lack,O
118491,11,of,O
118491,11,associated,O
118491,11,signs,O
118491,11,or,O
118491,11,symptoms,O
118491,11,of,O
118491,11,infection,O
118491,11,",",O
118491,11,therefore,O
118491,11,no,O
118491,11,further,O
118491,11,antibiotics,O
118491,11,were,O
118491,11,given,O
118491,11,.,O
118491,11,Acute,O
118491,11,alcoholic,O
118491,11,hepatitis,O
118491,11,was,O
118491,11,considered,O
118491,11,as,O
118491,11,a,O
118491,11,possible,O
118491,11,cause,O
118491,11,of,O
118491,11,leukocytosis,O
118491,11,",",O
118491,11,however,O
118491,11,there,O
118491,11,was,O
118491,11,no,O
118491,11,recent,O
118491,11,alcohol,O
118491,11,use,O
118491,11,to,O
118491,11,go,O
118491,11,along,O
118491,11,with,O
118491,11,this,O
118491,11,diagnosis,O
118491,11,.,O
118491,11,.,O
118491,11,On,O
118491,11,[,O
118491,11,**6-5**,O
118491,11,],O
118491,11,",",O
118491,11,UCx,O
118491,11,with,O
118491,11,VRE,O
118491,11,.,O
118491,11,On,O
118491,11,[,O
118491,11,**6-11**,O
118491,11,],O
118491,11,",",O
118491,11,pt,O
118491,11,'s,O
118491,11,blood,O
118491,11,cultures,O
118491,11,positive,O
118491,11,for,O
118491,11,VRE,B-Reason
118491,11,.,O
118491,11,Felt,O
118491,11,that,O
118491,11,PICC,O
118491,11,line,O
118491,11,was,O
118491,11,possible,O
118491,11,source,O
118491,11,;,O
118491,11,however,O
118491,11,",",O
118491,11,wound,O
118491,11,tip,O
118491,11,culture,O
118491,11,showed,O
118491,11,no,O
118491,11,growth,O
118491,11,.,O
118491,11,She,O
118491,11,was,O
118491,11,started,O
118491,11,on,O
118491,11,daptomycin,B-Drug
118491,11,and,O
118491,11,ceftriaxone,B-Drug
118491,11,per,O
118491,11,ID,O
118491,11,.,O
118491,11,Echocardiogram,O
118491,11,was,O
118491,11,negative,O
118491,11,for,O
118491,11,vegetation,O
118491,11,.,O
118491,11,On,O
118491,11,[,O
118491,11,**6-16**,O
118491,11,],O
118491,11,",",O
118491,11,a,O
118491,11,repeat,O
118491,11,chest,O
118491,11,CT,O
118491,11,was,O
118491,11,performed,O
118491,11,for,O
118491,11,further,O
118491,11,characterization,O
118491,11,of,O
118491,11,pulmonary,O
118491,11,nodules,O
118491,11,which,O
118491,11,revealed,O
118491,11,the,O
118491,11,interval,O
118491,11,development,O
118491,11,of,O
118491,11,diffuse,O
118491,11,hazy,O
118491,11,opacities,O
118491,11,thought,O
118491,11,to,O
118491,11,be,O
118491,11,consistent,O
118491,11,with,O
118491,11,PCP,O
118491,11,",",O
118491,11,[,O
118491,11,**Name10,O
118491,11,(,O
118491,11,NameIs,O
118491,11,),O
118491,11,7470**,O
118491,11,],O
118491,11,given,O
118491,11,that,O
118491,11,she,O
118491,11,was,O
118491,11,weaned,O
118491,12,off,O
118491,12,steroids,B-Drug
118491,12,for,O
118491,12,AIHA,B-Reason
118491,12,only,O
118491,12,days,O
118491,12,earlier,O
118491,12,.,O
118491,12,She,O
118491,12,was,O
118491,12,started,O
118491,12,emperically,O
118491,12,on,O
118491,12,treatment,O
118491,12,doses,O
118491,12,of,O
118491,12,bactrim,B-Drug
118491,12,however,O
118491,12,she,O
118491,12,continued,O
118491,12,to,O
118491,12,worsen,O
118491,12,.,O
118491,12,Diagnostic,O
118491,12,bronchoscopy,O
118491,12,was,O
118491,12,considered,O
118491,12,upon,O
118491,12,transfer,O
118491,12,to,O
118491,12,the,O
118491,12,ICU,O
118491,12,however,O
118491,12,the,O
118491,12,patient,O
118491,12,was,O
118491,12,too,O
118491,12,unstable,O
118491,12,for,O
118491,12,the,O
118491,12,procedure,O
118491,12,.,O
118491,12,Flagyl,B-Drug
118491,12,also,O
118491,12,emperically,O
118491,12,started,O
118491,12,for,O
118491,12,C.,B-Reason
118491,12,diff,I-Reason
118491,12,.,O
118491,12,.,O
118491,12,#,O
118491,12,Coagulopathy,B-Reason
118491,12,:,O
118491,12,[,O
118491,12,**1-15**,O
118491,12,],O
118491,12,liver,O
118491,12,disease,O
118491,12,.,O
118491,12,Pt,O
118491,12,has,O
118491,12,had,O
118491,12,multiple,O
118491,12,red,B-Drug
118491,12,blood,I-Drug
118491,12,cell,I-Drug
118491,12,transfusions,O
118491,12,",",O
118491,12,FFP,B-Drug
118491,12,",",O
118491,12,cryo,B-Drug
118491,12,",",O
118491,12,and,O
118491,12,platelets,B-Drug
118491,12,during,O
118491,12,admission,O
118491,12,.,O
118491,12,Also,O
118491,12,received,O
118491,12,ddAVP,B-Drug
118491,12,for,O
118491,12,uremic,B-Reason
118491,12,platelets,I-Reason
118491,12,.,O
118491,12,She,O
118491,12,had,O
118491,12,an,O
118491,12,episode,O
118491,12,of,O
118491,12,profuse,B-Reason
118491,12,epistaxis,I-Reason
118491,12,in,O
118491,12,the,O
118491,12,setting,O
118491,12,of,O
118491,12,trauma,O
118491,12,from,O
118491,12,Doboff,O
118491,12,feeding,O
118491,12,tube,O
118491,12,that,O
118491,12,could,O
118491,12,only,O
118491,12,be,O
118491,12,controlled,O
118491,12,with,O
118491,12,packing,O
118491,12,",",O
118491,12,Afrin,B-Drug
118491,12,and,O
118491,12,pressure,O
118491,12,by,O
118491,12,ENT,O
118491,12,.,O
118491,12,She,O
118491,12,also,O
118491,12,bled,O
118491,12,from,O
118491,12,her,O
118491,12,paracentesis,O
118491,12,site,O
118491,12,",",O
118491,12,requiring,O
118491,12,transfusion,O
118491,12,and,O
118491,12,sutures,O
118491,12,.,O
118491,12,She,O
118491,12,developed,O
118491,12,DIC,O
118491,12,and,O
118491,12,diffuse,O
118491,12,mucosal,O
118491,12,bleeding,O
118491,12,after,O
118491,12,becoming,O
118491,12,septic,O
118491,12,.,O
118491,12,.,O
118491,12,#,O
118491,12,Auto-Immune,B-ADE
118491,12,Hemolytic,I-ADE
118491,12,Anemia,I-ADE
118491,12,:,O
118491,12,Diagnosed,O
118491,12,with,O
118491,12,auto-immune,O
118491,12,hemolytic,O
118491,12,anemia,O
118491,12,at,O
118491,12,outside,O
118491,12,hospital,O
118491,12,",",O
118491,12,felt,O
118491,12,to,O
118491,12,be,O
118491,12,secondary,O
118491,12,to,O
118491,12,lasix,B-Drug
118491,12,.,O
118491,12,Re-consulted,O
118491,12,hematology,O
118491,12,here,O
118491,12,who,O
118491,12,agreed,O
118491,12,with,O
118491,12,this,O
118491,12,diagnosis,O
118491,12,.,O
118491,12,Lasix,B-Drug
118491,12,was,O
118491,12,held,O
118491,12,during,O
118491,12,admission,O
118491,12,and,O
118491,12,repeat,O
118491,12,coombs,O
118491,12,antibody,O
118491,12,negative,O
118491,12,.,O
118491,12,Reticulocyte,O
118491,12,count,O
118491,12,high,O
118491,12,on,O
118491,12,admission,O
118491,12,(,O
118491,12,29,O
118491,12,%,O
118491,12,),O
118491,12,",",O
118491,12,with,O
118491,12,elevated,O
118491,12,LDH,O
118491,12,",",O
118491,12,tbili,O
118491,12,",",O
118491,12,and,O
118491,12,decreasing,O
118491,12,hematocrit,O
118491,12,suggestive,O
118491,12,of,O
118491,12,ongoing,O
118491,12,hemolysis,O
118491,12,.,O
118491,12,However,O
118491,12,",",O
118491,12,hemolysis,O
118491,12,indices,O
118491,12,improved,O
118491,12,on,O
118491,12,prednisone,B-Drug
118491,12,",",O
118491,12,and,O
118491,12,slow,O
118491,12,prednisone,B-Drug
118491,12,taper,O
118491,12,initiated,O
118491,12,as,O
118491,12,indices,O
118491,12,stabilized,O
118491,12,.,O
118491,12,Blood,O
118491,12,counts,O
118491,12,supported,O
118491,12,as,O
118491,12,needed,O
118491,12,with,O
118491,12,blood,O
118491,12,transfusions,O
118491,12,(,O
118491,12,for,O
118491,12,hgb,O
118491,12,<,O
118491,12,7,O
118491,12,given,O
118491,12,difficult,O
118491,12,crossmatch,O
118491,12,(,O
118491,12,she,O
118491,12,has,O
118491,12,two,O
118491,12,antibodies,O
118491,12,),O
118491,12,.,O
118491,12,.,O
118491,12,#,O
118491,12,GI,O
118491,12,:,O
118491,12,EGD,O
118491,12,performed,O
118491,12,on,O
118491,12,this,O
118491,12,admission,O
118491,12,demonstrated,O
118491,12,grade,O
118491,12,1,O
118491,12,esophageal,O
118491,12,varices,O
118491,12,",",O
118491,12,a,O
118491,12,trans-endoscopic,O
118491,12,NJ,O
118491,12,feeding,O
118491,12,tube,O
118491,12,",",O
118491,12,and,O
118491,12,otherwise,O
118491,12,normal,O
118491,12,EGD,O
118491,12,to,O
118491,12,second,O
118491,12,part,O
118491,12,of,O
118491,12,the,O
118491,12,duodenum,O
118491,12,.,O
118491,12,.,O
118491,12,Medications,O
118491,12,on,O
118491,12,Admission,O
118491,12,:,O
118491,12,folic,B-Drug
118491,12,acid,I-Drug
118491,12,1,O
118491,12,mg,O
118491,12,Qday,O
118491,12,MVI,B-Drug
118491,12,with,I-Drug
118491,12,minerals,I-Drug
118491,12,thiamine,O
118491,12,100,O
118491,12,mg,O
118491,12,Qday,O
118491,12,prednisone,B-Drug
118491,12,45,O
118491,12,mg,O
118491,12,Qday,O
118491,12,spironolactone,B-Drug
118491,12,50,O
118491,13,mg,O
118491,13,Qday,O
118491,13,lactulose,B-Drug
118491,13,30,O
118491,13,ml,O
118491,13,[,O
118491,13,**Hospital1,O
118491,13,**,O
118491,13,],O
118491,13,Mg,B-Drug
118491,13,oxide,I-Drug
118491,13,400,O
118491,13,[,O
118491,13,**Hospital1,O
118491,13,**,O
118491,13,],O
118491,13,levoflox,B-Drug
118491,13,500,O
118491,13,mg,O
118491,13,IV,O
118491,13,Qday,O
118491,13,(,O
118491,13,day,O
118491,13,1,O
118491,13,:,O
118491,13,[,O
118491,13,**5-23**,O
118491,13,],O
118491,13,),O
118491,13,vancomycin,B-Drug
118491,13,750,O
118491,13,mg,O
118491,13,IV,O
118491,13,Qday,O
118491,13,(,O
118491,13,day,O
118491,13,1,O
118491,13,:,O
118491,13,[,O
118491,13,**5-23**,O
118491,13,],O
118491,13,),O
118491,13,ceftaz,B-Drug
118491,13,2g,O
118491,13,Q8H,O
118491,13,(,O
118491,13,day,O
118491,13,1,O
118491,13,:,O
118491,13,[,O
118491,13,**5-23**,O
118491,13,],O
118491,13,),O
118491,13,zofran,B-Drug
118491,13,4,O
118491,13,mg,O
118491,13,PO,O
118491,13,prn,O
118491,13,Discharge,O
118491,13,Medications,O
118491,13,:,O
118491,13,none,O
118491,13,Discharge,O
118491,13,Disposition,O
118491,13,:,O
118491,13,Expired,O
118491,13,Discharge,O
118491,13,Diagnosis,O
118491,13,:,O
118491,13,Primary,O
118491,13,Diagnoses,O
118491,13,:,O
118491,13,1,O
118491,13,.,O
118491,13,Alcoholic,O
118491,13,Cirrhosis,O
118491,13,2,O
118491,13,.,O
118491,13,Hepatic,O
118491,13,Encephalopathy,O
118491,13,3,O
118491,13,.,O
118491,13,Nutritional,O
118491,13,Deficiency,O
118491,13,Secondary,O
118491,13,Diagnoses,O
118491,13,:,O
118491,13,Discharge,O
118491,13,Condition,O
118491,13,:,O
118491,13,Expired,O
118491,13,Discharge,O
118491,13,Instructions,O
118491,13,:,O
118491,13,Expired,O
118491,13,Followup,O
118491,13,Instructions,O
118491,13,:,O
118491,13,none,O
